83 research outputs found
Cognitive ability and risk for substance misuse in men : genetic and environmental correlations in a longitudinal nation-wide family study.
Aims. To investigate the association between cognitive ability in late adolescence and
subsequent substance misuse-related events in men, and to study the underlying genetic and
environmental correlations. Design. A population-based longitudinal study with three
different family-based designs. Cox proportional hazards models were conducted to
investigate the association at the individual level. Bivariate quantitative genetic modeling in
(1) full brothers and maternal half-brothers, (2) full brothers reared together and apart, and (3)
monozygotic and dizygotic twin brothers was used to estimate genetic and environmental
correlations. Setting. Register-based study in Sweden.
Participants. The full sample included 1,402,333 Swedish men born 1958-1991 and
conscripted at mean age 18.2 (SD=0.5) years. 1,361,066 men who had no substance misuse
events before cognitive assessment at mandatory military conscription were included in the
Cox regression models with a follow-up time of up to 35.6 years. Measures. Cognitive ability
was assessed at conscription with the Swedish Enlistment Battery. Substance misuse events
included alcohol and drug related court convictions, medical treatments, and deaths, available
from governmental registries Findings. Lower cognitive ability in late adolescence predicted
an increased risk for substance misuse events (hazard ratio [HR] for a 1-stanine unit decrease
in cognitive ability: 1.29, 95% CI: 1.29-1.30). The association was somewhat attenuated
within clusters of full brothers (HR=1.21, 95% CI: 1.20-1.23). Quantitative genetic analyses
indicated that the association was primarily due to genetic influences; the genetic correlations
ranged between -.39 (95% CI: -.45, -.34) and -.52 (-.55, -.48) in the three different designs.
Conclusions. Our findings from different family designs indicate that shared genetic
influences underlie the association between low cognitive ability and subsequent risk for
substance misuse events.The Academy of FinlandThe Swedish Research Council for Health, Working Life and Welfare.The Swedish Research CouncilThe Swedish Research Council through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM)Manuscrip
Birth weight as an independent predictor of ADHD symptoms : a within-twin pair analysis
BACKGROUND: Studies have found an association between low birth weight and ADHD,
but the nature of this relation is unclear. First, it is uncertain whether birth
weight is associated with both of the ADHD dimensions, inattentiveness and
hyperactivity-impulsivity. Second, it remains uncertain whether the association
between birth weight and ADHD symptom severity is confounded by familial factors.
METHOD: Parents of all Swedish 9- and 12-year-old twins born between 1992 and
2000 were interviewed for DSM-IV inattentive and hyperactive-impulsive ADHD
symptoms by the Autism - Tics, AD/HD and other Comorbidities (A-TAC) inventory (N= 21,775 twins). Birth weight was collected prospectively through the Medical
Birth Registry. We used a within-twin pair design to control for genetic and
shared environmental factors.
RESULTS: Reduced birth weight was significantly
associated with a mean increase in total ADHD (beta = -.42; 95% CI: -.53, -.30),
inattentive (beta = -.26; 95% CI: -.33, -.19), and hyperactive-impulsive (beta =
-.16; 95% CI: -.22, -.10) symptom severity. These results imply that a change of
one kilogram of birth weight corresponded to parents rating their child nearly
one unit higher (going from "no" to "yes, to some extent" on a given symptom) on
the total ADHD scale. These associations remained within pairs of MZ and DZ
twins, and were also present when restricting the analyses to full term births.
CONCLUSIONS: There is an independent association between low birth weight and all
forms of ADHD symptoms, even after controlling for all environmental and genetic
confounds shared within twin pairs. These results indicate that fetal growth
restriction (as reflected in birth weight differences within twin pairs) and/or
the environmental factors which influence it is in the casual pathway leading to
ADHD.The Swedish Council for Working Life and Social ResearchThe Swedish Research CouncilManuscrip
Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims
There is growing evidence that opioid prescribing in the United States follows a pattern in which patients who are at the highest risk of adverse outcomes from opioids are more likely to receive long-term opioid therapy. These patients include, in particular, those with substance use disorders (SUDs) and other psychiatric conditions. This study examined health insurance claims among 10,311,961 patients who filled prescriptions for opioids. Specifically, we evaluated how opioid receipt differed among patients with and without a wide range of preexisting psychiatric and behavioral conditions (ie, opioid and nonopioid SUDs, suicide attempts or other self-injury, motor vehicle crashes, and depressive, anxiety, and sleep disorders) and psychoactive medications (ie, antidepressants, benzodiazepines, hypnotics, mood stabilizers, antipsychotics, and medications used for SUD, tobacco cessation, and attention-deficit/hyperactivity disorder). Relative to those without, patients with all assessed psychiatric conditions and medications had modestly greater odds of subsequently filling prescriptions for opioids and, in particular, substantially greater risk of long-term opioid receipt. Increases in risk for long-term opioid receipt in adjusted Cox regressions ranged from approximately 1.5-fold for prior attention-deficit/hyperactivity disorder medication prescriptions (hazard ratio [HR] = 1.53; 95% confidence interval [CI], 1.48-1.58) to approximately 3-fold for prior nonopioid SUD diagnoses (HR = 3.15; 95% CI, 3.06-3.24) and nearly 9-fold for prior opioid use disorder diagnoses (HR = 8.70; 95% CI, 8.20-9.24). In sum, we found evidence of greater opioid receipt among commercially insured patients with a breadth of psychiatric conditions. Future studies assessing behavioral outcomes associated with opioid prescribing should consider preexisting psychiatric conditions
Association of Mental Health Conditions and Treatments With Long-term Opioid Analgesic Receipt Among Adolescents
Importance:
Adults with mental health conditions are more likely than those without to receive long-term opioid therapy. Less is known about opioid therapy among adolescents, especially those with mental health conditions.
Objective:
To examine associations between preexisting mental health conditions and treatments and initiation of any opioid and long-term opioid therapy among adolescents.
Design, Setting, and Participants:
A cohort of 1 224 520 incident opioid recipients without cancer diagnoses aged 14 to 18 years at first receipt was extracted from nationwide commercial health care claims data from January 1, 2003, to December 31, 2014. Analysis was conducted from August 19, 2016, to November 16, 2017. Associations between preexisting mental health conditions and treatments and any opioid receipt were examined by comparing recipients with nonrecipients matched on sex, calendar year and years of age of first enrollment, and months of enrollment (prior to the index month for recipients, ever for nonrecipients). Associations between preexisting mental health conditions and treatments and subsequent long-term opioid therapy were examined among recipients with at least 6 months' follow-up using Cox proportional hazards regressions adjusted for demographics.
Exposures:
Mental health condition diagnoses and treatments recorded in inpatient, outpatient, and filled-prescription claims prior to opioid receipt.
Main Outcomes and Measures:
Opioid receipt, defined as any opioid analgesic prescription claim, and long-term opioid therapy, defined as more than 90 days' supply within a 6-month window having no gaps in supply of more than 32 days.
Results:
Of the 1 224 520 new opioid recipients included, the median age at first receipt was 17 years (interquartile range, 16-18 years), and 51.1% were female. Median follow-up after first receipt was 625 days (interquartile range, 255-1268 days). Adolescents with anxiety, mood, neurodevelopmental, sleep, and nonopioid substance use disorders and most mental health treatments were significantly more likely to receive any opioid (odds ratios from 1.13 [95% CI, 1.10-1.16] for nonopioid substance use disorders to 1.69 [95% CI, 1.58-1.81] for nonbenzodiazepine hypnotics). Among the 1 000 453 opioid recipients (81.7%) who had at least 6 months' follow-up, the cumulative incidence of long-term opioid therapy was 3.0 (95% CI, 2.8-3.1) per 1000 recipients within 3 years after first opioid receipt. All preexisting mental health conditions and treatments were strongly associated with higher rates of long-term opioid therapy (adjusted hazard ratios from 1.73 [95% CI 1.54-1.95] for attention-deficit/hyperactivity disorder to 8.90 [95% CI, 5.85-13.54] for opioid use disorder).
Conclusions and Relevance:
Commercially insured adolescents with many types of preexisting mental health conditions and treatments were modestly more likely to receive any opioid and were substantially more likely to subsequently transition to long-term opioid therapy relative to those without, although overall rates of long-term opioid therapy were low
Recommended from our members
Association between pharmacotherapy for ADHD in offspring and depression-related specialty care visits by parents with a history of depression
Background
Pharmacotherapy is effective in reducing the core symptoms of attention-deficit/hyperactivity disorder (ADHD). We aimed to investigate the concurrent association between pharmacotherapy for ADHD in offspring and depression-related specialty care visits by the parents with a history of depression.
Methods
Using data from a variety of Swedish national registers, we conducted a cohort study with 8-year follow-up of 5605 parents (3872 mothers and 1733 fathers) who had a history of depression and an offspring diagnosed with ADHD. The hazard rate for parental depression-related specialty care visits during exposed periods when the offspring was on medication for treatment of ADHD was compared with the hazard rate during unexposed periods when the offspring was off medication. Within-individual comparisons were employed to control for time-constant confounding factors.
Results
Among mothers, the crude rates of depression-related specialty care visits during exposed and unexposed periods were 61.33 and 63.95 per 100 person-years, respectively. The corresponding rates among fathers were 49.23 and 54.65 per 100 person-years. When the same parent was compared with him or herself, fathers showed a decreased hazard rate for depression-related visits during exposed periods when the offspring was on medication for treatment of ADHD as compared to unexposed periods (hazard ratio, 0.79 [95% confidence interval, 0.70 to 0.90]). No statistically significant associations were observed in mothers.
Conclusions
Among parents with a history of depression, pharmacotherapy for ADHD in offspring is concurrently associated with a decreased rate of depression-related specialty care visits in fathers but not in mothers. Future research with refined measures of parental depression and other time-varying familial factors is needed to better understand the mechanisms underlying the association
A family-based study of the association between labor induction and offspring attention-deficit hyperactivity disorder and low academic achievement
The current study examined associations between labor induction and both (1)
offspring attention-deficit hyperactivity disorder (ADHD) diagnosis in a Swedish
birth cohort born 1992-2005 (n = 1,085,008) and (2) indices of offspring low
academic achievement in a sub-cohort born 1992-1997 (n = 489,196). Associations
were examined in the entire sample (i.e., related and unrelated individuals) with
adjustment for measured covariates and, in order to account for unmeasured
confounders shared within families, within differentially exposed cousins and
siblings. We observed an association between labor induction and offspring ADHD
diagnosis and low academic achievement in the population. However, these
associations were fully attenuated after adjusting for measured covariates and
unmeasured factors that cousins and siblings share. The results suggest that
observed associations between labor induction and ADHD and low academic
achievement may be due to genetic and/or shared environmental factors that
influence both mothers' risk of labor induction and offspring neurodevelopment.NoneAccepte
A genetically informed study of the associations between maternal age at childbearing and adverse perinatal outcomes
We examined associations of maternal age at childbearing (MAC) with gestational
age and fetal growth (i.e., birth weight adjusting for gestational age), using
two genetically informed designs (cousin and sibling comparisons) and data from
two cohorts, a population-based Swedish sample and a nationally representative
United States sample. We also conducted sensitivity analyses to test limitations
of the designs. The findings were consistent across samples and suggested that,
associations observed in the population between younger MAC and shorter
gestational age were confounded by shared familial factors; however, associations
of advanced MAC with shorter gestational age remained robust after accounting for
shared familial factors. In contrast to the gestational age findings, neither
early nor advanced MAC was associated with lower fetal growth after accounting
for shared familial factors. Given certain assumptions, these findings provide
support for a causal association between advanced MAC and shorter gestational
age. The results also suggest that there are not causal associations between
early MAC and shorter gestational age, between early MAC and lower fetal growth,
and between advanced MAC and lower fetal growth.NonePublishe
Labor epidural analgesia and subsequent risk of offspring autism spectrum disorder and attention-deficit/hyperactivity disorder : A cross-national cohort study of 4.5 million individuals and their siblings
Background A recent study has suggested that labor epidural analgesia may be associated with increased rates of offspring autism spectrum disorder (ASD). Subsequent replication attempts have lacked sufficient power to confidently exclude the possibility of a small effect and the causal nature of this association remains unknown. Objective To investigate the extent to which exposure to labor epidural analgesia is associated with offspring ASD and attention-deficit/hyperactivity disorder (ADHD) following adjustments for unmeasured familial confounding. Study design We identified 4,498,462 singletons and their parents using the Medical Birth Registers in Finland (cohorts born 1987-2005), Norway (1999-2015), and Sweden (1987-2011), linked with population and patient registries. These cohorts were followed from birth until they either had the outcomes of interest, emigrated, died, or reached the end of the follow-up (at mean ages 13.6-16.8 years), whichever occurred first. Cox regression models were used to estimate country-specific associations between labor epidural analgesia recorded at birth and outcomes (e.g., at least one secondary care diagnosis of ASD and ADHD or at least one dispensed prescription of medication used for the treatment of ADHD). The models were adjusted for sex, birth year, birth order, and unmeasured familial confounders via sibling-comparisons. Pooled estimates across all three countries were estimated using inverse variance weighted fixed-effects meta-analysis models. Results A total of 4,498,462 individuals (48.7% female) were included, 1,091,846 (24.3%) of which were exposed to labor epidural analgesia. Of these, 1.2% were diagnosed with ASD and 4.0% with ADHD. On the population level, pooled estimates showed that labor epidural analgesia was associated with increased risk of offspring ASD (adjusted hazard ratio, aHR=1.12; 95% CI: 1.10-1.14, absolute risks: 1.20% vs. 1.07%) and ADHD (aHR=1.20; 1.19-1.21; 3.95% vs. 3.32%). However, when comparing full-siblings who were differentially exposed to labor epidural analgesia, the associations were fully attenuated for both conditions, with narrow confidence intervals (aHRASD=0.98; 0.93-1.03; aHRADHD=0.99; 0.96-1.02). Conclusion In this large cross-national study, we found no support for the hypothesis that exposure to labor epidural analgesia causes either offspring ASD or ADHD.Peer reviewe
Physiological Correlates of Volunteering
We review research on physiological correlates of volunteering, a neglected but promising research field. Some of these correlates seem to be causal factors influencing volunteering. Volunteers tend to have better physical health, both self-reported and expert-assessed, better mental health, and perform better on cognitive tasks. Research thus far has rarely examined neurological, neurochemical, hormonal, and genetic correlates of volunteering to any significant extent, especially controlling for other factors as potential confounds. Evolutionary theory and behavioral genetic research suggest the importance of such physiological factors in humans. Basically, many aspects of social relationships and social activities have effects on health (e.g., Newman and Roberts 2013; Uchino 2004), as the widely used biopsychosocial (BPS) model suggests (Institute of Medicine 2001). Studies of formal volunteering (FV), charitable giving, and altruistic behavior suggest that physiological characteristics are related to volunteering, including specific genes (such as oxytocin receptor [OXTR] genes, Arginine vasopressin receptor [AVPR] genes, dopamine D4 receptor [DRD4] genes, and 5-HTTLPR). We recommend that future research on physiological factors be extended to non-Western populations, focusing specifically on volunteering, and differentiating between different forms and types of volunteering and civic participation
Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19
Introduction: Cerebral venous sinus thrombosis associated with vaccine-induced immune thrombotic thrombocytopenia (CVST-VITT) is a severe disease with high mortality. There are few data on sex differences in CVST-VITT. The aim of our study was to investigate the differences in presentation, treatment, clinical course, complications, and outcome of CVST-VITT between women and men. Patients and methods: We used data from an ongoing international registry on CVST-VITT. VITT was diagnosed according to the Pavord criteria. We compared the characteristics of CVST-VITT in women and men. Results: Of 133 patients with possible, probable, or definite CVST-VITT, 102 (77%) were women. Women were slightly younger [median age 42 (IQR 28–54) vs 45 (28–56)], presented more often with coma (26% vs 10%) and had a lower platelet count at presentation [median (IQR) 50x109/L (28–79) vs 68 (30–125)] than men. The nadir platelet count was lower in women [median (IQR) 34 (19–62) vs 53 (20–92)]. More women received endovascular treatment than men (15% vs 6%). Rates of treatment with intravenous immunoglobulins were similar (63% vs 66%), as were new venous thromboembolic events (14% vs 14%) and major bleeding complications (30% vs 20%). Rates of good functional outcome (modified Rankin Scale 0-2, 42% vs 45%) and in-hospital death (39% vs 41%) did not differ. Discussion and conclusions: Three quarters of CVST-VITT patients in this study were women. Women were more severely affected at presentation, but clinical course and outcome did not differ between women and men. VITT-specific treatments were overall similar, but more women received endovascular treatment.</p
- …